trending Market Intelligence /marketintelligence/en/news-insights/trending/vW04FZ1D4wQRzHtMOan2mA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Valeant Pharmaceuticals closes debt offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Valeant Pharmaceuticals closes debt offering

Valeant Pharmaceuticals International Inc. said it completed an offering of $1 billion of 5.500% senior secured notes due Nov. 1, 2025.

The company used the net proceeds of the offering, along with cash on hand, to repurchase $1 billion of notes of its unit Valeant Pharmaceuticals International, consisting of $431.3 million of 7.000% senior notes due 2020 and $568.7 million of 6.375% senior notes due 2020 pursuant to a tender offer and to pay related fees and expenses.

The Bank of New York Mellon served as trustee and the notes collateral agents party.